Literature DB >> 9871706

Potent antimitotic and cell growth inhibitory properties of substituted chalcones.

S Ducki1, R Forrest, J A Hadfield, A Kendall, N J Lawrence, A T McGown, D Rennison.   

Abstract

A series of substituted chalcones was synthesised and screened for cytotoxic activity against the K562 human leukaemia cell line. (E)-3-(3"-Hydroxy-4"-methoxyphenyl)-2-methyl-1-(3',4',5'- trimethoxyphenyl)-prop-2-en-1-one [IC50 (K562) 0.21 nM] was found to be the most active. A relationship between the conformation and cytotoxicity of the chalcones is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871706     DOI: 10.1016/s0960-894x(98)00162-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  37 in total

1.  Design, synthesis, and biological evaluations of 2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoline analogs of combretastatin-A4.

Authors:  Lauren Lee; Lyda M Robb; Megan Lee; Ryan Davis; Hilary Mackay; Sameer Chavda; Balaji Babu; Erin L O'Brien; April L Risinger; Susan L Mooberry; Moses Lee
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

2.  Synthesis, electronic, and spectral properties of novel geranylated chalcone derivatives: a theoretical and experimental study.

Authors:  J C Espinoza-Hicks; J M Nápoles-Duarte; G V Nevárez-Moorillón; A Camacho-Dávila; L M Rodríguez-Valdez
Journal:  J Mol Model       Date:  2016-10-03       Impact factor: 1.810

3.  Synthesis and biological evaluation of structurally diverse α-conformationally restricted chalcones and related analogues.

Authors:  Casey J Maguire; Graham J Carlson; Jacob W Ford; Tracy E Strecker; Ernest Hamel; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2019-06-04       Impact factor: 3.597

4.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

5.  A boronic acid chalcone analog of combretastatin A-4 as a potent anti-proliferation agent.

Authors:  Yali Kong; Kan Wang; Michael C Edler; Ernest Hamel; Susan L Mooberry; Mikell A Paige; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2009-11-10       Impact factor: 3.641

Review 6.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

7.  One-pot diastreoselective synthesis of highly functionalized cyclohexenones: 2-oxo-N,4,6-triarylcyclohex-3-enecarboxamides.

Authors:  Mir Rasul Mousavi; Malek Taher Maghsoodlou; Sayyed Mostafa Habibi-Khorassani
Journal:  Mol Divers       Date:  2014-08-06       Impact factor: 2.943

8.  Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.

Authors:  Lívia B Salum; Wanessa F Altei; Louise D Chiaradia; Marlon N S Cordeiro; Rafael R Canevarolo; Carolina P S Melo; Evelyn Winter; Bruno Mattei; Hikmat N Daghestani; Maria Cláudia Santos-Silva; Tânia B Creczynski-Pasa; Rosendo A Yunes; José A Yunes; Adriano D Andricopulo; Billy W Day; Ricardo J Nunes; Andreas Vogt
Journal:  Eur J Med Chem       Date:  2013-03-06       Impact factor: 6.514

9.  Straightforward synthesis of thiazoline-incorporated chalconoids from phenacyl halides.

Authors:  Adile Ayati; Saeed Emami
Journal:  Mol Divers       Date:  2013-01-12       Impact factor: 2.943

Review 10.  Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs.

Authors:  Subhash Padhye; Aamir Ahmad; Nikhil Oswal; Fazlul H Sarkar
Journal:  J Hematol Oncol       Date:  2009-09-02       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.